Noul Co.,Ltd. (376930.KQ)
KOSDAQ · KRW · Healthcare · Diagnostics & Research
₩2,015 (-7.14%) as of
Key statistics
- Market cap
- 20.67B
- Dividend yield
- 0.00%
- 52-week range
- 1,151.00 – 15,925.00
- Beta
- -0.47
- Revenue (TTM)
- 3.66B
- Profit margin
- 0.00%
- Volume
- 6.74M
About Noul Co.,Ltd.
Noul Co.,Ltd. engages in the in-vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, immunohistochemistry services, and digital cervical cell analysis solution. Noul Co.,Ltd. was incorporated in 2015 and is headquartered in Yongin-si, South Korea.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Headquarters
- Yongin-si, South Korea
- Employees
- 104
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.